Device Trial Radar · NCT04896476
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
Last checked: Nov 20, 2026Latest source record: May 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Jan 21, 2022
Primary completion
Oct 24, 2023
Study completion Apr 30, 2026
Sponsor
- Lead sponsor
- Sonavex, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- May 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi-center trial to assess the feasibility and safety of the EchoMark LP and the EchoMark diagnostic ultrasound system for assessing AV fistula blood flow, diameter, and depth.
Conditions
- Kidney Diseases
- Arteriovenous Fistula
Interventions
EchoMark / EchoSureDevice
The EchoMark is to be secured a minimum of 3 cm away from the anastomosis. The follow-up EchoSure scans will be conducted by the designated EchoSure user without the investigator and without the sonographer/RVT conducting the Duplex exam in the room, either during the routine work-up prior to the surgeon seeing the patient or after. The EchoSure results for flow, and vessel depth and diameter are shown as numerical values on the screen of the EchoSure device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: 30 Days
- Primary Feasibility EndpointTime frame: 4 Months
- Rate of Technical Success Defined as the Successful Ability to Determine Blood Flow, Diameter, and Depth Measurements Using the EchoSure Diagnostic Ultrasound System. Technical Success Will be Assessed From Baseline to 4 Months.Time frame: 4 Months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Trinity Research Group
Dothan, Alabama
SKI Vascular Center
Peoria, Arizona
Michgan Vascular Center
Flint, Michigan
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.